Fifth Dimension Catalog Contact Us
|
||
|
|
|
|
RC280.B8 - Breast Cancers Issues
|
||
- RC280.B8.B1.1 - Activities of Daily Living for Post Breast Therapy
Judy Bray, OC and Mary Godfrey, OTR - Specific daily living and self-care skills should
be incorporated into your exercise program. Your goal is to resume your
normal way of daily life
http://www.cancersupportivecare.com/adl.html
First appeared 1999-05-01; updated 2007-08-19 - RC280.B8.B24.1 - Impact of aging on the biology of breast cancer - Part 1
Christopher Benz, MD - Breast cancer is a heterogeneous malignancy; its age-specific incidence profile rises exponentially until menopause and increases more slowly thereafter, reflecting the superimposition of early-onset and late-onset breast cancer rates. Geroscience is still in its infancy. Emergent molecular and cellular hypotheses put forth to explain the cancer-aging relationship are of interest but remain largely untested.
http://www.cancersupportivecare.com/breastage1.html
First appeared 2008-02-18 - RC280.B8.B24.2 - Impact of aging on the biology of breast cancer - Part 2
Christopher Benz, MD - Initial studies comparing early-onset and late-onset ER-positive breast cancers for DNA mutations and whole genome aberrations as well as RNA transcriptome differences suggest that epigenetic changes rather than genotypic variation account for most of the age-dependent biological and clinical differences observed in hormone-dependent breast cancer.
http://www.cancersupportivecare.com/breastage2.html
First appeared 2008-02-18 - RC280.B8.B24.3 - Impact of aging on the biology of breast cancer - Acknowledgments, Biography and References
Christopher Benz, MD - Director of the Buck Institute's Program on Cancer and Developmental Therapeutics, Dr. Benz's translational research program focuses on identifying molecular strategies to improve breast cancer diagnostics and therapeutics, with a special emphasis on trying to understand and interrupt the link between breast cancer and aging, Also incudes Acknowledgments and References
http://www.cancersupportivecare.com/breastageref.html
First appeared 2008-02-18 - RC280.B8.B24.4 - Impact of aging on the biology of breast cancer - PDF version
Christopher Benz, MD - Breast cancer is a heterogeneous malignancy; its age-specific incidence profile rises exponentially until menopause and increases more slowly thereafter, reflecting the superimposition of early-onset and late-onset breast cancer rates.
http://www.cancersupportivecare.com/breastage.pdf
First appeared 2008-02-18 - RC280.B8.G76.1 - Breast Cancer Epidemiology and Hormone Replacement Therapy and Breast Cancer
Mindy Goldman, MD - Overview of Breast Cancer Epidemiology and Hormone Replacement Therapy, and Oral Contraceptives
http://www.cancersupportivecare.com/breasthrt.html
First appeared 2002-10-02; updated 2007-08-19 - RC280.B8.K86.1 - What You Hear And What It Really Means
Patricia T. Kelly, PhD - In the US, the
average woman has a 1 in 8 or 1 in 9 risk of breast cancer. Actually,
the average woman's risk is 2% up to age 50 and 11% to age 80.
http://www.cancersupportivecare.com/hear.html
First appeared 2001-07-03; updated 2007-08-19 - RC280.B8.K86.2 - Hormone Replacement Therapy
Patricia T. Kelly, PhD - An understanding of the studies on hormone
replacement therapy (HRT) and breast cancer risk is essential to help
women make informed decisions about hormone use and prophylactic
oophorectomy.
http://www.cancersupportivecare.com/hrt.html
First appeared 2001-08-28; updated 2007-08-19 - RC280.B8.M41.1 - Post Breast Therapy Rehabilitation Exercises
Francine Manuel, RPT and Lisa Glassberg (Demonstrator) - The following exercise program will help initiate
your recovery. You can begin exercising as soon as you have permission
from your physician
http://www.cancersupportivecare.com/breastexercise.html
First appeared 2002-06-12; updated 2007-08-19 - RC280.B8.M98.1 - Frequently Asked Questions about Tamoxifen
Sharon Mitchell, PharmD, UCSF & Robert Ignoffo, PharmD, Clinical Professor UCSF - The hormone, estrogen, enters many normal cells
including mammary (breast) cells and signals growth and multiplication.
In breast cancer, this growth is accelerated. Tamoxifen is an
anti-estrogen
http://www.cancersupportivecare.com/tamoxifen.html
First appeared 2003-01-09; updated 2007-08-19 - RC280.B8.R39.1 - Breast Cancer and Side Effects
Ernest H. Rosenbaum, MD - Information about breast cancer side effects of treatments including sexual dysfunction, osteoporosis, osteonecrosis, cardiovascular events and more.
http://www.cancersupportivecare.com/breastside.html
First appeared 2007-08-21; updated 2014-12-16 - RC280.B8.R39.2 - Breast Cancer Evaluation
Ernest H. Rosenbaum, MD - Information about secondary breast cancer recurrences.
http://www.cancersupportivecare.com/breasteval.html
First appeared 2007-08-21; updated 2014-12-16 - RC280.B8.R39.3 - Breast Cancer Screening Guidelines
Ernest H. Rosenbaum, MD - Information about secondary breast cancers, recurrences and recommended guidelines for follow up.
http://www.cancersupportivecare.com/breastguide.html
First appeared 2007-08-21; updated 2014-12-16 - RC280.B8.R39.4 - Breast Cancer Cognitive Dysfunction Problems
Ernest H. Rosenbaum, MD - Information about breast cancer evaluation, side effects of treatments including sexual and cognitive dysfunction, osteoporosis, osteonecrosis, cardiovascular events, secondary cancers and recurrences and recommended guidelines for follow up.
http://www.cancersupportivecare.com/breastcognitive.html
First appeared 2007-08-21; updated 2014-12-16 - RC280.B8.T34.1 - New Hormonal Therapy - the Aromatase Inhibitors
Debu Tripathy, MD - Manipulating the function of hormones, particularly estrogen has long been a useful tool in treating breast cancer
http://www.cancersupportivecare.com/aromatase.html
First appeared 2002-03-20; updated 2007-08-19 - RC280.B8.W90.1 - Overview Of The Sentinel Lymph Node Concept
Robert A. Wascher, MD, FACS - Sentinel Lymph Node mapping has revolutionized the care
of patients with melanoma, and more recently, breast cancer patients as
well
http://www.cancersupportivecare.com/sentinelnode.html
First appeared 2002-10-20; updated 2007-08-19
|
You are welcome to share this © article with friends, but do not forget to include the author name and web address. Permission needed to use articles on commercial and non commercial websites. Thank you. |